Page last updated: 2024-09-02

2,3-bis(3'-hydroxybenzyl)butyrolactone and Bone Loss, Perimenopausal

2,3-bis(3'-hydroxybenzyl)butyrolactone has been researched along with Bone Loss, Perimenopausal in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brüggemann-Rotgans, IE; Kardinaal, AF; Morton, MS; van Beresteijn, EC1

Other Studies

1 other study(ies) available for 2,3-bis(3'-hydroxybenzyl)butyrolactone and Bone Loss, Perimenopausal

ArticleYear
Phyto-oestrogen excretion and rate of bone loss in postmenopausal women.
    European journal of clinical nutrition, 1998, Volume: 52, Issue:11

    Topics: 4-Butyrolactone; Aging; Bone Density; Chromans; Equol; Estrogens, Non-Steroidal; Female; Gas Chromatography-Mass Spectrometry; Genistein; Humans; Isoflavones; Lignans; Linear Models; Middle Aged; Osteoporosis, Postmenopausal; Phytoestrogens; Plant Preparations; Postmenopause; Prospective Studies; Time Factors

1998
chemdatabank.com